Difference between revisions of "Contexts"
Jump to navigation
Jump to search
m |
|||
(2 intermediate revisions by the same user not shown) | |||
Line 2: | Line 2: | ||
=FDA indication language= | =FDA indication language= | ||
+ | ==Early stage== | ||
==Locally advanced== | ==Locally advanced== | ||
+ | ==Advanced== | ||
+ | ==Advanced or metastatic== | ||
==Metastatic== | ==Metastatic== | ||
==Relapsed or refractory== | ==Relapsed or refractory== | ||
==Untreated== | ==Untreated== | ||
+ | AKA: Newly diagnosed | ||
=Treatment contexts= | =Treatment contexts= |
Latest revision as of 01:45, 12 April 2021
The purpose of this page is to define treatment contexts used in the HemOnc ontology; it is not for other purposes at this time.
FDA indication language
Early stage
Locally advanced
Advanced
Advanced or metastatic
Metastatic
Relapsed or refractory
Untreated
AKA: Newly diagnosed